Manning & Napier Advisors LLC Astrazeneca PLC Transaction History
Manning & Napier Advisors LLC
- $7.84 Trillion
- Q3 2025
A detailed history of Manning & Napier Advisors LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Manning & Napier Advisors LLC holds 1,762,193 shares of AZN stock, worth $158 Million. This represents 1.72% of its overall portfolio holdings.
Number of Shares
1,762,193
Previous 2,152,535
18.13%
Holding current value
$158 Million
Previous $150 Billion
10.12%
% of portfolio
1.72%
Previous 1.79%
Shares
6 transactions
Others Institutions Holding AZN
# of Institutions
1,502Shares Held
500MCall Options Held
5.64MPut Options Held
3.2M-
Price T Rowe Associates Inc Baltimore, MD49.1MShares$4.39 Billion0.4% of portfolio
-
Primecap Management CO Pasadena, CA39.9MShares$3.56 Billion2.42% of portfolio
-
Bank Of America Corp Charlotte, NC32.6MShares$2.92 Billion0.18% of portfolio
-
Wellington Management Group LLP Boston, MA32.3MShares$2.89 Billion0.45% of portfolio
-
Capital International Investors Los Angeles, CA25.1MShares$2.24 Billion0.33% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $277B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...